Humana Inc. (NYSE:HUM) Stock Has Average Price Target of $453.30 According to Analysts

Key Points

• Analysts maintain a Moderate Buy consensus on Humana, with 21 buy, 10 hold and 1 sell rating among 32 analysts. The average 12-month price target is $453.30, with recent targets ranging from $475 to $520.
• Humana’s shares fell 4.5% to $412.78, though the stock remains above its 50-day and 200-day moving averages. Institutional investors own 92.38% of the company, with several firms increasing their holdings.
• The insurer exceeded quarterly expectations, reporting $7.61 in EPS versus a $7.27 consensus and $40.89 billion in revenue, up 26.2% year over year. Humana also declared a quarterly dividend of $0.885 per share, representing a 0.9% yield.

Shares of Humana Inc. (NYSE:HUM - Get Free Report) have earned an average recommendation of "Moderate Buy" from the thirty-two research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twenty-one have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $453.30.

A number of research analysts have issued reports on HUM shares. Citigroup initiated coverage on Humana in a research note on Friday, October 9th. They issued a "buy" rating for the company. Leerink Partners upgraded Humana from a "market perform" rating to an "outperform" rating and set a $513.00 price target for the company in a report on Thursday, July 30th. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $520.00 price target on the stock in a research report on Monday, October 12th. Truist Financial lifted their price objective on Humana from $415.00 to $475.00 and gave the company a "hold" rating in a report on Monday. Finally, Zacks Research cut Humana from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 11th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Vontobel Holding Ltd. boosted its holdings in shares of Humana by 12.2% in the third quarter. Vontobel Holding Ltd. now owns 2,145 shares of the insurance provider's stock valued at $818,000 after buying an additional 234 shares during the period. TD Waterhouse Canada Inc. increased its position in shares of Humana by 2.0% during the third quarter. TD Waterhouse Canada Inc. now owns 12,056 shares of the insurance provider's stock worth $4,575,000 after acquiring an additional 237 shares in the last quarter. V Square Quantitative Management LLC raised its holdings in shares of Humana by 8.7% during the third quarter. V Square Quantitative Management LLC now owns 2,746 shares of the insurance provider's stock worth $1,048,000 after acquiring an additional 220 shares during the period. Assenagon Asset Management S.A. raised its holdings in shares of Humana by 20,126.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider's stock worth $479,053,000 after acquiring an additional 1,249,272 shares during the period. Finally, Mather Group LLC. lifted its position in Humana by 58.3% in the 3rd quarter. Mather Group LLC. now owns 527 shares of the insurance provider's stock valued at $201,000 after acquiring an additional 194 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Trading Down 4.5%

HUM traded down $19.42 during mid-day trading on Friday, hitting $412.78. The stock had a trading volume of 1,401,592 shares, compared to its average volume of 1,610,763. The stock's fifty day simple moving average is $394.10 and its 200-day simple moving average is $342.41. The firm has a market capitalization of $49.57 billion, a price-to-earnings ratio of 39.05, a price-to-earnings-growth ratio of 2.66 and a beta of 0.74. Humana has a 1-year low of $163.11 and a 1-year high of $456.50. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the previous year, the business earned $6.27 EPS. The firm's revenue was up 26.2% on a year-over-year basis. As a group, research analysts forecast that Humana will post 9.03 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be issued a dividend of $0.8850 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana's dividend payout ratio (DPR) is 33.49%.

Humana Company Profile

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana's insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.